Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis

Abstract The present study aimed to construct and evaluate a novel experiment-based hypoxia signature to help evaluations of GBM patient status. First, the 426 proteins, which were previously found to be differentially expressed between normal and hypoxia groups in glioblastoma cells with statistica...

Full description

Bibliographic Details
Main Authors: Ya-Dan Wen, Xiao-San Zhu, Dong-Jie Li, Qing Zhao, Quan Cheng, Yun Peng
Format: Article
Language:English
Published: Nature Publishing Group 2021-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-95980-x
id doaj-9d017c41dd784021a3e27503e2f8153b
record_format Article
spelling doaj-9d017c41dd784021a3e27503e2f8153b2021-08-29T11:24:31ZengNature Publishing GroupScientific Reports2045-23222021-08-0111111410.1038/s41598-021-95980-xProteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesisYa-Dan Wen0Xiao-San Zhu1Dong-Jie Li2Qing Zhao3Quan Cheng4Yun Peng5Department of Clinical Pharmacology, Xiangya Hospital, Central South UniversityDepartment of Gastroenterology, Chenggong Hospital, Xiamen UniversityDepartment of Geriatric Urology, Xiangya International Medical Center, Xiangya Hospital, Central South UniversityDepartment of Clinical Pharmacology, Xiangya Hospital, Central South UniversityDepartment of Neurosurgery, Xiangya Hospital, Central South UniversityDepartment of Geriatrics, Xiangya Hospital, Central South UniversityAbstract The present study aimed to construct and evaluate a novel experiment-based hypoxia signature to help evaluations of GBM patient status. First, the 426 proteins, which were previously found to be differentially expressed between normal and hypoxia groups in glioblastoma cells with statistical significance, were converted into the corresponding genes, among which 212 genes were found annotated in TCGA. Second, after evaluated by single-variable Cox analysis, 19 different expressed genes (DEGs) with prognostic value were identified. Based on λ value by LASSO, a gene-based survival risk score model, named RiskScore, was built by 7 genes with LASSO coefficient, which were FKBP2 , GLO1, IGFBP5, NSUN5, RBMX, TAGLN2 and UBE2V2. Kaplan–Meier (K–M) survival curve analysis and the area under the curve (AUC) were plotted to further estimate the efficacy of this risk score model. Furthermore, the survival curve analysis was also plotted based on the subtypes of age, IDH, radiotherapy and chemotherapy. Meanwhile, immune infiltration, GSVA, GSEA and chemo drug sensitivity of this risk score model were evaluated. Third, the 7 genes expression were evaluated by AUC, overall survival (OS) and IDH subtype in datasets, importantly, also experimentally verified in GBM cell lines exposed to hypoxic or normal oxygen condition, which showed significant higher expression in hypoxia than in normal group. Last, combing the hypoxia RiskScore with clinical and molecular features, a prognostic composite nomogram was generated, showing the good sensitivity and specificity by AUC and OS. Meanwhile, univariate analysis and multivariate analysis were used for performed to identify variables in nomogram that were significant in independently predicting duration of survival. It is a first time that we successfully established and validated an independent prognostic risk model based on hypoxia microenvironment from glioblastoma cells and public database. The 7 key genes may provide potential directions for future biochemical and pharmaco-therapeutic research.https://doi.org/10.1038/s41598-021-95980-x
collection DOAJ
language English
format Article
sources DOAJ
author Ya-Dan Wen
Xiao-San Zhu
Dong-Jie Li
Qing Zhao
Quan Cheng
Yun Peng
spellingShingle Ya-Dan Wen
Xiao-San Zhu
Dong-Jie Li
Qing Zhao
Quan Cheng
Yun Peng
Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
Scientific Reports
author_facet Ya-Dan Wen
Xiao-San Zhu
Dong-Jie Li
Qing Zhao
Quan Cheng
Yun Peng
author_sort Ya-Dan Wen
title Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
title_short Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
title_full Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
title_fullStr Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
title_full_unstemmed Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis
title_sort proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (gbm) pathogenesis
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-08-01
description Abstract The present study aimed to construct and evaluate a novel experiment-based hypoxia signature to help evaluations of GBM patient status. First, the 426 proteins, which were previously found to be differentially expressed between normal and hypoxia groups in glioblastoma cells with statistical significance, were converted into the corresponding genes, among which 212 genes were found annotated in TCGA. Second, after evaluated by single-variable Cox analysis, 19 different expressed genes (DEGs) with prognostic value were identified. Based on λ value by LASSO, a gene-based survival risk score model, named RiskScore, was built by 7 genes with LASSO coefficient, which were FKBP2 , GLO1, IGFBP5, NSUN5, RBMX, TAGLN2 and UBE2V2. Kaplan–Meier (K–M) survival curve analysis and the area under the curve (AUC) were plotted to further estimate the efficacy of this risk score model. Furthermore, the survival curve analysis was also plotted based on the subtypes of age, IDH, radiotherapy and chemotherapy. Meanwhile, immune infiltration, GSVA, GSEA and chemo drug sensitivity of this risk score model were evaluated. Third, the 7 genes expression were evaluated by AUC, overall survival (OS) and IDH subtype in datasets, importantly, also experimentally verified in GBM cell lines exposed to hypoxic or normal oxygen condition, which showed significant higher expression in hypoxia than in normal group. Last, combing the hypoxia RiskScore with clinical and molecular features, a prognostic composite nomogram was generated, showing the good sensitivity and specificity by AUC and OS. Meanwhile, univariate analysis and multivariate analysis were used for performed to identify variables in nomogram that were significant in independently predicting duration of survival. It is a first time that we successfully established and validated an independent prognostic risk model based on hypoxia microenvironment from glioblastoma cells and public database. The 7 key genes may provide potential directions for future biochemical and pharmaco-therapeutic research.
url https://doi.org/10.1038/s41598-021-95980-x
work_keys_str_mv AT yadanwen proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
AT xiaosanzhu proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
AT dongjieli proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
AT qingzhao proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
AT quancheng proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
AT yunpeng proteomicsbasedprognosticsignatureandnomogramconstructionofhypoxiamicroenvironmentondeterioratingglioblastomagbmpathogenesis
_version_ 1721186839277076480